Table 2.
Line | Strain* | C8-OMe† | C8-H† | C8-OMe/C8-H |
---|---|---|---|---|
ID50, μg/ml | ||||
1 | DM4100 (WT) | 0.12 ± 0.03 | 0.039 ± 0.006 | 3 |
2 | GP201 (gyrAR) | 1.2 ± 0.07 | 0.82 ± 0.039 | 1.5 |
3 | KD1366 (gyrAR parCR)‡ | 2.1 ± 0.27 | 3.1 ± 0.13 | 0.67 |
ID50 ratio | ||||
4 | GP201/DM4100 | 10 | 21 | |
5 | KD1366/GP201 | 1.8 | 3.8 | |
% survivors at 5-fold ID50§ | ||||
6 | DM4100 (WT) | 0.07 | 1.15 | 1/16 |
7 | GP201 (gyrAR) | 0.11 | 6.3 | 1/57 |
WT, wild type; gyrAR, NalR; parCR, CipR.
Fluoroquinolones tested were PD161148 (C8-OMe) and PD160793 (C8-H). Values of ID50 are means ± SD.
Nearly identical results were obtained for the gyrAR parCR strain KD1368.
Cells were treated with fluoroquinolone for 1 hr, after which they were diluted and plated on LB agar. Colonies were counted after 16 hr of incubation at 37°C.